Asset Details
Do you wish to reserve the book?
Clinicopathological spectrum of biopsy-proven renal diseases in a tertiary hospital
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Clinicopathological spectrum of biopsy-proven renal diseases in a tertiary hospital
Do you wish to request the book?
Clinicopathological spectrum of biopsy-proven renal diseases in a tertiary hospital
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Clinicopathological spectrum of biopsy-proven renal diseases in a tertiary hospital
2025
Overview
Abstract Background: Renal disorders require a renal biopsy for accurate diagnosis, effective treatment planning, and assessing the extent of active and chronic histologic changes. Objective: To evaluate the spectrum of renal diseases diagnosed by renal biopsy and its clinical correlation. Methodology: This was a four-year retrospective study carried out from January 2019 to December 2022 at Ain Shams University Hospitals. Patients' demographic data and clinical presenrations were extracted from available data sheets. All specimens were examined using light and electron microscopy and stained with immunofluorescence or immunohistochemical techniques. The results were organized according to the most recent classification system. Results: A total of 1851 renal biopsy specimens were studied (52.4 % males), with a mean patient age of 38.43±14.83 years. 346 patients (18.7%) presented nephrotic syndrome, and 322 patients (17.4%) had lupus nephritis as a secondary complication. The majority of patients with glomerulonephritis had hypertensive nephrosclerosis; 694 patients (37.5 %) had membranous glomerulonephritis. 124 patients (6.7 %) were diagnosed with IgA nephropathy. Most of them presented with asymptomatic hematuria. 52 patients (2.8 %) were diagnosed with thrombotic microangio pathy, all of them presented with acute kidney injury. 35 patients (1.9 %) were diagnosed with tubulointerstitial diseases; however, it was associated with other renal pathology diagnoses. Conclusion: The most frequently observed diagnosis was hypertensive nephrosclerosis, with lupus nephritis being the most prevalent form of secondary glomerulonephritis. Membranous glomerulonephritis was the most common kind of primary glomerulonephritis.
Publisher
Asociación Colombiana de Nefrología e Hipertensión Arterial
